| RS398123529 |
GBA1
|
Health Risk |
Pathogenic |
— |
| RS398123530 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome, Gaucher disease type I |
| RS398123531 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123532 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome, Gaucher disease type I |
| RS398123538 |
IQCB1
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 5, Retinitis pigmentosa |
| RS398123540 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS398123546 |
G6PD
|
Health Risk |
Pathogenic |
Anemia, nonspherocytic hemolytic |
| RS398123547 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
Anemia, nonspherocytic hemolytic |
| RS398123552 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
Anemia, nonspherocytic hemolytic |
| RS398123555 |
FKTN
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS398123557 |
FKTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS398123558 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123559 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123560 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS398123561 |
TCF4
|
Health Risk |
Pathogenic |
Intellectual disability, Pitt-Hopkins syndrome |
| RS398123562 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS398123563 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS398123567 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS398123568 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS398123569 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS398123570 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS398123572 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS398123573 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS398123574 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS398123575 |
EYS
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS398123576 |
EYS
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 25 |
| RS398123577 |
NDE1
|
Health Risk |
Pathogenic |
— |
| RS398123578 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS398123579 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS398123580 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS398123581 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS398123584 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS398123585 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Migraine |
| RS398123588 |
SCN1A
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy, Seizure |
| RS398123589 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS398123590 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS398123591 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS398123592 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS398123593 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS398123594 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS398123595 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS398123596 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS398123597 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS398123598 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS398123599 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS398123600 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS398123603 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS398123606 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS398123607 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS398123613 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS398123614 |
FLNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Oto-palato-digital syndrome, type II |
| RS398123615 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS398123616 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS398123617 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS398123618 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Familial thoracic aortic aneurysm and aortic dissection |
| RS398123619 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS398123620 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS398123621 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS398123623 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS398123624 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS398123626 |
CDH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123627 |
CLCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123628 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS398123630 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS398123631 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Sensorimotor neuropathy |
| RS398123632 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 1A, Bethlem myopathy 1A |
| RS398123633 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS398123634 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS398123635 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS398123636 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS398123637 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS398123638 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS398123639 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS398123640 |
COL6A1
|
Health Risk |
Pathogenic |
Limb-girdle muscle weakness, EMG abnormality |
| RS398123641 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123643 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS398123644 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS398123645 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS398123646 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS398123649 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS398123650 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS398123652 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123653 |
CPT1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyl transferase 1A deficiency, CPT1A-related disorder |
| RS398123654 |
CPT1A
|
Health Risk |
Pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS398123658 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123660 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 2 |
| RS398123662 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123663 |
DBT
|
Health Risk |
Likely pathogenic |
— |
| RS398123664 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123665 |
DBT
|
Health Risk |
Pathogenic |
— |
| RS398123666 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123667 |
DBT
|
Health Risk |
Pathogenic |
— |
| RS398123668 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 2, Maple syrup urine disease type 1A |
| RS398123669 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 2 |
| RS398123672 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123674 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease type 2, Maple syrup urine disease type 2 |
| RS398123675 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS398123676 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 2 |
| RS398123679 |
IVD
|
Health Risk |
Conflicting classifications of pathogenicity |
Isovaleryl-CoA dehydrogenase deficiency, IVD-related disorder |
| RS398123680 |
IVD
|
Health Risk |
Conflicting classifications of pathogenicity |
Isovaleryl-CoA dehydrogenase deficiency, IVD-related disorder |